Name | Title | Contact Details |
---|
Bionik Laboratories (OTCQB: BNKL), is a global, pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders. Through the acquisition of Interactive Motion Technologies, Bionik has added a portfolio of products focused on upper and lower extremity rehabilitation of stroke patients.
PLANMECA USA is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pontotoc Technology Center (PTC) has a diverse economy with a large health community including Mercy Hospital, Chickasaw Nation Health System and Rolling Hills Psychiatric Hospital. Pontotoc also has a large mining sector with Holcim, Unimin, and Fairmount Minerals, a large manufacturing sector with Flex-N-Gate and Solo Cup and a large service industry with Pre Paid Legal Services dba Legal Shield and Interactive Response Technologies. These diverse sectors are served in a rural setting.
Physicians' Medical Service Bureau Inc is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.